Our automated, AI-driven molecular diagnostic platforms leverage cutting-edge technology to deliver accurate, comprehensive, and reliable results. Our RPP Panel uses advanced molecular testing technologies to rapidly identify a broad range of infection-causing pathogens on modern, high-complexity and high-performance platforms.

This comprehensive and powerful multiplex test can simultaneously detect multiple respiratory pathogens in less than one hour, enabling faster diagnosis and more informed treatment decisions.